Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic Adenocarcinoma
NCT04812808
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Pancreas Cancer
Interventions
DRUG:
Bazedoxifene 20 mg
Sponsor
Hôpital Fribourgeois